Loncar & Associates is reviewing potential claims regarding Crestor and its potential side effects. Crestor is an anti-cholesterol drug called a statin. Manufactured by AstraZeneca Pharmaceuticals, LP, Crestor was designed to help reduce “bad” cholesterol while raising “good” cholesterol but has been linked to serious and potentially life-threatening cardiovascular side effects.
The FDA initially withheld approval for Crestor following concerns related to the recall of Baycol and the kidney and muscle side effects reported in Crestor drug trials that were similar to those associated with Baycol. In May 2002, the FDA told AstraZeneca that it would need to address these concerns before the FDA would approve use in the United States. The FDA approved Crestor in August 2003 for the 5, 10, 20, and 40 mg doses following a clinical trial involving approximately 12,000 patients. The 80 mg dosage was not approved.
In 2005, AstraZeneca finally revised the package insert, warning of the increased risk of kidney failure and rhabdomyolysis. Despite the warnings, Crestor sales continue to rise due to the marketing efforts of AstraZeneca.
Cardiovascular side effects from Crestor use are serious and may be debilitating or life-threatening. If you or a loved one experienced a cardiovascular injury, including acute myocardial infarction (heart attack), acute congestive heart failure, diabetes, immune-mediated necrotizing myopathy, or death while on Crestor, you should contact our office at 1-800-285-4878, or use one of the options on the right to speak with an experienced member of our Mass Torts staff.
